An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinical efficiency of personalised cancer treatments to an unprecedented level.

Project description

Innovative imaging platform for cancer diagnosis and evaluation of treatment efficacy

Fields of science

• medical and health sciences › basic medicine › neurology › dementia › alzheimer
• medical and health sciences › clinical medicine › oncology › lung cancer
• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › basic medicine › immunology › immunotherapy
• medical and health sciences › medical biotechnology › cells technologies

Programme(s)

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Topic(s)

• SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme

Call for proposal

H2020-SMEInst-2016-2017

See other projects for this call

Sub call

H2020-SMEINST-1-2016-2017

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

FASTBASE SOLUTIONS SOCIEDAD LIMITADA

Net EU contribution

€ 50 000,00

Address

C/ Areatza Hiribidea 47
48620 Plentzia
Spain

Region

Noreste › País Vasco › Bizkaia

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00